[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated: Thursday, 10 February, 2005, 17:05 GMT
Glaxo aims high after profit fall
Pills being poured into a bottle
Cheaper generic rivals have continued to hit sales
GlaxoSmithKline saw its profits fall 9% last year to 6.2bn ($11.5bn), but Europe's biggest drugmaker says a recovery during 2005 is on the way.

Cheap copies of its drugs, particularly anti-depressants Paxil and Wellbutrin, and a weak dollar had hit profits, but global sales were up 1% in 2004.

The firm is confident its new drug pipeline will deliver profits despite the failure of an obesity drug.

Chief executive Jean-Pierre Garnier said it had been a "difficult year".

2005 will also be an important year in terms of research and development pipeline progress
Jean-Pierre Garnier, GSK chief executive

Shares in the group closed 4 pence higher at 1236 pence on the London market.

Mr Garnier said the company had absorbed over 1.5bn of lost sales to generics but still managing to grow the business.

"The continuing success of our key products means we can now look forward to a good performance in 2005," he said.

"2005 will also be an important year in terms of research and development pipeline progress."

However, the firm discontinued development of an experimental treatment for obesity, known as '771, after disappointing clinical trial results.

Glaxo is relying on new treatments for conditions such as cancer, diabetes, depression, HIV/AIDS and allergies to lift the pace of sales growth after several disappointing years.





SEE ALSO:
GSK faces anti-depressant lawsuit
06 Sep 04 |  Business
Glaxo settles New York drug suit
27 Aug 04 |  Business
Cut-price competition hits Glaxo
27 Jul 04 |  Business
Glaxo releases drug trials on web
18 Jun 04 |  Business


RELATED INTERNET LINKS:
The BBC is not responsible for the content of external internet sites


PRODUCTS AND SERVICES

News Front Page | Africa | Americas | Asia-Pacific | Europe | Middle East | South Asia
UK | Business | Entertainment | Science/Nature | Technology | Health
Have Your Say | In Pictures | Week at a Glance | Country Profiles | In Depth | Programmes
Americas Africa Europe Middle East South Asia Asia Pacific